Delivery Order SPE2DB20D3103-SPE2DB25FP7Q2
Award Date 8/6/25
Potential Completion Date 8/7/25
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FYCOMPA 0.5 mg/mL oral suspension (340 mL) on July 14, 2025, with a ceiling value of $1,935.66. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location. FYCOMPA is an antiepileptic medication...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of FYCOMPA 12 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $2,152.34. This is a competitively awarded, non-set-aside delivery order with an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a $6,828.86 delivery order to AmerisourceBergen Drug Corp for FYCOMPA 0.5 mg/ml oral suspension (340ml) on November 7, 2025, with completion targeted for November 10, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $7,307.89 to AmerisourceBergen Drug Corp for Fycompa 0.5 mg/ml oral suspension (340ml) on July 18, 2025. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, with performance to occur at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,169.95 to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Fycompa 0.5 mg/ml oral suspension in a 340 ml unit. This is a firm fixed-price delivery order with an ultimate completion date of October 27, 2025, and represents a non-competitive set-aside contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $4,169.69 delivery order to AmerisourceBergen Drug Corp for FYCOMPA 6 mg tablets (30-count) on August 20, 2025, with completion scheduled for August 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,040.59 to AmerisourceBergen Drug Corp for FYCOMPA 8 mg tablets (30-count packages) on September 12, 2025, with an ultimate completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. FYCOMPA (perampanel) is a neurological medication used as an adjunctive treatment for epilepsy and seizure...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of FYCOMPA 4 mg tablets (30-count units) with a ceiling value of $3,134.37. This firm fixed-price delivery order, which has an ultimate completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $1,224.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 2 mg tablets (30-count units) on October 20, 2025, with an ultimate completion date of October 21, 2025. This non-competitive delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. FYCOMPA (perampanel) is an oral antiepileptic medication used in the treatment of seizure disorders, reflecting the Defense Logistics Agency...
- The Defense Logistics Agency awarded a delivery order valued at $1,033.98 to AmerisourceBergen Drug Corp for FYCOMPA 4 mg tablets (30-count) on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price contract, executed without a set-aside designation, represents a competitively awarded delivery order supporting federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...